NIH will soon fund feasibility studies needed to plan future clinical trials, aiming to improve trial design, recruitment, and methods for greater public health impact.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
NIH will offer funding for large-scale trials in real-world health care settings to test and implement interventions, aiming to inform decision-makers about their effectiveness, risks, and benefits.
NIH will fund investigator-initiated multi-site or decentralized clinical trials relevant to its mission, supporting planning and implementation over up to 7 years using a milestone-driven UG3/UH3 grant mechanism.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.
This grant funds clinical trials testing mental health treatment and services interventions in community settings to improve access and quality.